They demonstrated that its recombinant version, rLZ-8, induced cycle arrest and apoptosis by downregulating the expression of EGFR and inhibiting EGFR downstream effectors, AKT and ERK1/2 in lung cancer cells. Here, EGFR is linked to lung carcinoma.